Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
1801
DELISTED
Accelerate Diagnostics
AXDX
| $2.33M | ﹤0.01% |
14,421
+13,093
| +986% | +$2.83M |
|
1802
Hyster-Yale Materials Handling
HY
$624M
| $2.32M | ﹤0.01% |
40,164
+7,428
| +23% | +$474K |
|
|
LHCG
1803
DELISTED
LHC Group LLC
LHCG
| $2.32M | ﹤0.01% |
51,881
+23,910
| +85% | +$1.05M |
|
1804
CALL
Aramark
ARMK
$15.6B
| $2.32M | ﹤0.01% |
+108,446
| New | +$2.48M |
|
|
ADT
1805
DELISTED
ADT Corp
ADT
| $2.31M | ﹤0.01% |
77,406
-212,873
| -73% | -$6.9M |
|
1806
Coca-Cola Femsa
KOF
$24.6B
| $2.31M | ﹤0.01% |
33,341
+14,826
| +80% | +$1.09M |
|
1807
Southern Copper
SCCO
$186B
| $2.31M | ﹤0.01% |
+94,183
| New | +$2.37M |
|
|
S
1808
PUT
DELISTED
Sprint Corporation
S
| $2.3M | ﹤0.01% |
+600,000
| New | +$2.53M |
|
|
ACHN
1809
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.3M | ﹤0.01% |
+332,229
| New | +$2.71M |
|
1810
CALL
Crown Holdings
CCK
$13.1B
| $2.29M | ﹤0.01% |
+50,000
| New | +$2.53M |
|
|
ANTH
1811
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $2.29M | ﹤0.01% |
46,957
+40,563
| +634% | +$2.83M |
|
|
SRRA
1812
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.28M | ﹤0.01% |
+2,774
| New | +$3.13M |
|
1813
HNI Corp
HNI
$3.6B
| $2.27M | ﹤0.01% |
+52,927
| New | +$2.52M |
|
|
HTS
1814
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $2.27M | ﹤0.01% |
149,523
-226,723
| -60% | -$3.7M |
|
1815
Forrester Research
FORR
$229M
| $2.26M | ﹤0.01% |
72,021
+38,590
| +115% | +$1.27M |
|
1816
Otter Tail
OTTR
$3.83B
| $2.26M | ﹤0.01% |
+86,868
| New | +$2.29M |
|
1817
UnitedHealth
UNH
$356B
| $2.26M | ﹤0.01% |
19,508
-526,962
| -96% | -$63.1M |
|
1818
Cracker Barrel
CBRL
$1.3B
| $2.26M | ﹤0.01% |
15,339
-173,646
| -92% | -$26M |
|
1819
Hancock Whitney
HWC
$5.99B
| $2.26M | ﹤0.01% |
83,483
-970,458
| -92% | -$27.5M |
|
1820
Strategic Education
STRA
$1.91B
| $2.26M | ﹤0.01% |
41,033
+30,793
| +301% | +$1.58M |
|
1821
Fomento Económico Mexicano
FMX
$42.1B
| $2.25M | ﹤0.01% |
+25,199
| New | +$2.24M |
|
|
ADAP
1822
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.25M | ﹤0.01% |
187,823
+70,006
| +59% | +$989K |
|
1823
CALL
Meta Platforms (Facebook)
META
$1.45T
| $2.25M | ﹤0.01% |
+25,000
| New | +$2.29M |
|
|
HEP
1824
DELISTED
Holly Energy Partners, L.P.
HEP
| $2.23M | ﹤0.01% |
+77,000
| New | +$2.4M |
|
|
WPZ
1825
CALL
DELISTED
Williams Partners L.P.
WPZ
| $2.23M | ﹤0.01% |
70,000
-55,000
| -44% | -$2.3M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.